Autoimmunity and its treatment in aplastic anemia

Annals of Internal Medicine

Volumn 126, Issue 2, 1997, Pages 166-168

  Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; PURINE DERIVATIVE; THYMOCYTE ANTIBODY;

APLASTIC ANEMIA; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; EDITORIAL; ETIOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL;

EID: 0031025354     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-2-199701150-00014     Document Type: Editorial

References (22)

1. Vaquez MH, Aubertin C. L'ané mie pernicieuse d'aprè s les conceptions actuelles. Bulletins et Mé moires de la Socié té Mé dicale des Hô pitaux de Paris. 1904; 21: 288-97.
2. Maciejewski JP, Selleri C, Sato T, Andersen SA. Young NS. A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. Blood. 1996; 88: 1983-91.
3. Champlin RE, Feig SA, Sparkes RS, Galen RP. Bone marrow transplantation from identical twins in the treatment of aplastic anaemia: implication for the pathogenesis of the disease. Br J Haematol. 1984; 56: 455-63.
4. Hinterberger W, Rowlings PA, Hinterberger-Fischer M, Gibson J, Jacobsen N, Klein JP, et al. Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med. 1997; 126: 116-22.
5. Mathé G, Amiel JL, Schwarzenberg L, Choay J, Trolard P, Schneider M. et al. Bone marrow graft in man after conditioning by antilymphocytic serum. BrMed J. 1970; 2: 131-6.
6. Young NS, Alter BP. Aplastic Anemia, Acquired and Inherited. Philadelphia: WB Saunders; 1994.
7. Selleri C, Maciejewski JP, Sato T, Young NS. Interferon-gamma constitutively expressed in the stromal microenviroment of human marrow cultures mediates potent hematopoietic inhibition. Blood. 1996: 87: 4149-57.
8. + human marrow cells is induced by Interferon γ and tumor necrosis factor a and potentiates cytokine: mediated hematopoietic suppression in vitro. Blood. 1995: 85: 3183-90.
9. Frickhofen N, Kaltwasser IP. Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, et al. Treatment of aplastic anemia with antithymocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med. 1991; 324: 1297-304.
10. Bacigalupo A, Broccia G. Corda G, Arcese W, Carotenuto M, Gallamini A, et al. Antilymphocyte globulin, cydosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (5AA): a pilot study of the EBMT SAA Working Party. Blood. 1995: 85: 1348-53.
11. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppresion with antithymocyte globulin and cyclosporine as treatment for severe acquire aplastic anemia. Blood. 1995: 85: 3058-65.
12. Paquette RU Tebyani N, Frane M, Ireland P, Ho WG, Champlï n RE, et al. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood. 1995; 85: 283-90.
13. Arranz R, Otero MJ, Ramos R, Steegman JL, Lamana ML, Tomas If. et al. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy. Bone Marrow Transplant. 1994: 13: 383-7.
14. Speck B, Tichelli A, Gratwohl A, Nissen C. Treatment of severe aplastic anemia: a 12-year follow-up of patients after bone marrow transplantation or after therapy with antilymphocyte globulin. In: Shahidi NT, ed. Aplastic Anemia and Other Bone Marrow Failure Syndromes. New York: Springer; Verlag: 1990: 96-103.
15. Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol. 1988; 70: 177-82.
16. Young NS, Barren AJ. The treatment of severe acquired aplastic anemia. Blood. 1995: 85: 3367-77.
17. Doney K, Leisenring W, Storb R. Appelbaum FR. Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team. Ann Intern Med. 1997; 126: 107-15.
18. Schrezenmeier H, Marin P, Raghavachar A, McCann S, Hows J, Gluckman E, et al. Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. Br J Haematol. 1993; 85: 371-7.
19. Sodé G, Henry-Amar M. Bacigalupo A, Hows J, Tichelli A, Ljungman P, et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med. 1993: 329: 1152-7.
20. Champlin RE, Horowitz MM, van Bekkum DW, Camilla BM, Elfenbein GE, Gale RP, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood. 1989; 73: 606-13.
21. Crump M, La r rait LM. Maki E. Curt is JE, Minden MD, Meharchand JM, et al. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation. Am J Med. 1992: 92: 596-602.
22. Brodsky RA, Sensenbrenner LL, Jones RJ. Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation. Blood. 1996: 87: 491-4.